INTANGIBLE ASSETS (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Apr. 30, 2025 |
Apr. 30, 2024 |
Apr. 30, 2023 |
|
| Indefinite-Lived Intangible Assets [Line Items] | |||
| Intangible asset | $ 1,549,427 | $ 1,549,427 | |
| Intangible asset, impairment | 0 | (2,000,000) | |
| Cytochrome P 450 [Member] | |||
| Indefinite-Lived Intangible Assets [Line Items] | |||
| Intangible asset | 1,549,427 | 1,549,427 | $ 3,549,427 |
| Intangible asset, impairment | $ 0 | $ (2,000,000) | |
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|